Remodeling

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Remodeling.php on line 2
Remodeling

LE WE PMID CA

Remodeling

2393

Remodeling

ADAMTS7

Blood vessels (Physiology)

Blood vessels (Resistance artery)

COPD

Dishevelled1

Fibrosis

Gelsolin

Heart (Arrhythmia)

Heart (Coronary heart disease BASKET)

Heart (MRT)

Heart failure (chronical)

HIF1alpha und HIF1 (BASKET)

Histone deacetylase

RAAS (Local Heart)

Remodeling

Sarcoplasmic reticulum

T cell (Th2)

TGF beta

Wnt beta Catenin TCF

1992 1	Ventricular remodelling after myocardial infarction. [1389754] Br Heart J 68(3): 257-9 (1992)
1982 2	Myocardial disarray. A critical review. [7044398] Br Heart J 47(6): 527-38 (1982)
2009 3	Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy. [19619418] Comp Med 59(3): 272-9 (2009)
2006 4	Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies. [16971981] Can J Cardiol 22(11): 953-68 (2006)
2009 5	Myocardial repair/remodelling following infarction: roles of local factors. [19050008] Cardiovasc Res 81(3): 482-90 (2009)
2009 6	Oxidative stress and left ventricular remodelling after myocardial infarction. [19047340] Cardiovasc Res 81(3): 457-64 (2009)
2009 7	Energy metabolism in heart failure and remodelling. [18987051] Cardiovasc Res 81(3): 412-9 (2009)
2009 8	Post-infarct remodelling: contribution of wound healing and inflammation. [18977766] Cardiovasc Res 81(3): 474-81 (2009)
2009 9	Mitochondrial oxidative stress and dysfunction in myocardial remodelling. [18854381] Cardiovasc Res 81(3): 449-56 (2009)
2009 10	Metabolic remodelling of the failing heart: beneficial or detrimental? [18854380] Cardiovasc Res 81(3): 420-8 (2009)
2009 11	Subcellular remodelling may induce cardiac dysfunction in congestive heart failure. [18852252] Cardiovasc Res 81(3): 429-38 (2009)
2009 12	Macro- and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. [18835843] Cardiovasc Res 81(3): 500-8 (2009)
2009 13	Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. [18826964] Cardiovasc Res 81(3): 491-9 (2009)
2009 14	Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. [18779231] Cardiovasc Res 81(3): 465-73 (2009)
2009 15	Biochemical markers of myocardial remodelling in hypertensive heart disease. [18762556] Cardiovasc Res 81(3): 509-18 (2009)
2008 16	Heart-rate reduction and beta-blockade in early post-infarction cardiac remodelling. [18487234] Cardiovasc Res 79(1): 5-6 (2008)
2008 17	Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of beta1-adrenoceptors. [18281371] Cardiovasc Res 78(1): 5-7 (2008)
2008 18	Cardiac alpha 1-adrenergic drive in pathological remodelling. [18032391] Cardiovasc Res 77(3): 452-62 (2008)
2006 19	Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. [16483558] Cardiovasc Res 71(2): 280-8 (2006)
2005 20	Myocyte apoptosis in heart failure. [15896727] Cardiovasc Res 67(1): 21-9 (2005)
2004 21	Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. [15485678] Cardiovasc Res 64(2): 198-207 (2004)
2004 22	Matricellular proteins in the heart: possible role during stress and remodeling. [15364610] Cardiovasc Res 64(1): 24-31 (2004)
2004 23	Synchronization and integration of multiple hypertrophic pathways in the heart. [15276461] Cardiovasc Res 63(3): 367-72 (2004)
2004 24	Tachycardia-induced remodeling: atria and ventricles take a different route. [15249176] Cardiovasc Res 63(2): 194-5 (2004)
2002 25	Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. [11922892] Cardiovasc Res 53(4): 822-30 (2002)
1997 26	Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process. [9302342] Cardiovasc Res 35(1): 6-12 (1997)
1997 27	Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. [9231026] Cardiovasc Res 34(3): 439-44 (1997)
2002 28	Quantitative assessment of airway remodeling using high-resolution CT. [12475796] Chest 122(6 Suppl): 271S-275S (2002)
2007 29	Angiotensin-converting enzyme and vascular remodeling. [17761934] Circ Res 101(5): 441-54 (2007)
2006 30	Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. [17008597] Circ Res 99(7): 675-91 (2006)
2000 31	Arterial remodeling. Mechanisms and clinical implications. [10973850] Circulation 102(10): 1186-91 (2000)
2000 32	Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. [10869273] Circulation 101(25): 2981-8 (2000)
1995 33	Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. [7743609] Circulation 91(10): 2504-7 (1995)
2008 34	Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. [18490430] Eur Heart J 29(12): 1485-94 (2008)
2007 35	Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling. [17766634] Eur Respir J 30(3): 574-88 (2007)
2007 36	Clinical relevance of airway remodelling in airway diseases. [17601971] Eur Respir J 30(1): 134-55 (2007)
2007 37	Allergen-induced airway remodelling. [17470623] Eur Respir J 29(5): 1020-32 (2007)
2007 38	Tools used to measure airway remodelling in research. [17329494] Eur Respir J 29(3): 596-604 (2007)
2007 39	Basic mechanisms of development of airway structural changes in asthma. [17264325] Eur Respir J 29(2): 379-89 (2007)
2006 40	The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. [16387953] Eur Respir J 27(1): 208-29 (2006)
2004 41	Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? [15293595] Eur Respir J 24(1): 1-2 (2004)
1994 42	Vascular remodelling in the lung. [8162972] Eur Respir J 7(2): 217-9 (1994)
2008 43	Mechanisms of arterial remodeling in hypertension: coupled roles of wall shear and intramural stress. [18541735] Hypertension 52(2): 195-200 (2008)
2001 44	Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. [11566935] Hypertension 38(3 Pt 2): 581-7 (2001)
2007 45	ECM remodeling in hypertensive heart disease. [17332884] J Clin Invest 117(3): 568-75 (2007)
2006 46	A look between the cardiomyocytes: the extracellular matrix in heart failure. [16438481] Mayo Clin Proc 81(1): 71-6 (2006)
2000 47	Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. [10716457] J Am Coll Cardiol 35(3): 569-82 (2000)
1999 48	Molecular mechanisms of myocardial remodeling. [9922372] Physiol Rev 79(1): 215-62 (1999)
2010 49	Wnt signaling molecules in left ventricular remodeling: focus on dishevelled 1. [20176999] Hypertension 55(4): 852-4 (2010)
2007 50	Cardiac hypertrophy and the Wnt/Frizzled pathway. [17210831] Hypertension 49(3): 427-8 (2007)
2007 51	Hypertensive cardiac remodeling in males and females: from the bench to the bedside. [17242305] Hypertension 49(3): 401-7 (2007)
2007 52	Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. [17339567] Circulation 115(9): 1090-100 (2007)
2002 53	Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. [11861412] Circ Res 90(3): 251-62 (2002)
2010 54	WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. [21071717] Circ Res 107(10): 1198-208 (2010)
2009 55	Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling. [19359605] Circ Res 104(7): 829-31 (2009)
2007 56	Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon. [17541029] Arterioscler Thromb Vasc Biol 27(8): 1722-8 (2007)
2010 57	'Turning the right screw': targeting the interleukin-6 receptor to reduce unfavourable tissue remodelling after myocardial infarction. [20558440] Cardiovasc Res 87(3): 395-6 (2010)
2010 58	Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. [20164116] Cardiovasc Res 86(2): 236-42 (2010)
2004 59	TGF-beta1 and angiotensin networking in cardiac remodeling. [15276467] Cardiovasc Res 63(3): 423-32 (2004)
2004 60	Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure. [15276468] Cardiovasc Res 63(3): 433-42 (2004)
2009 61	Potential novel pharmacological therapies for myocardial remodelling. [19019834] Cardiovasc Res 81(3): 519-27 (2009)
2007 62	The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. [17109837] Cardiovasc Res 74(2): 184-95 (2007)
2008 63	Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling. [18006436] Cardiovasc Res 77(2): 315-24 (2008)
2009 64	What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease? [20008873] Proc Am Thorac Soc 6(8): 668-72 (2009)
2006 65	Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. [16799085] Proc Am Thorac Soc 3(5): 418-23 (2006)
2009 66	Infarct haemorrhage detected by cardiac magnetic resonance imaging: are we seeing the latest culprit in adverse left ventricular remodelling? [19460842] Eur Heart J 30(12): 1431-3 (2009)
2009 67	Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. [19147603] Eur Heart J 30(3): 266-77 (2009)
2009 68	Autophagy, redox signaling, and ventricular remodeling. [19327038] Antioxid Redox Signal 11(8): 1975-88 (2009)
2005 69	New aspects of vascular remodelling: the involvement of all vascular cell types. [15894533] Exp Physiol 90(4): 469-75 (2005)
2005 70	Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. [15890798] Exp Physiol 90(4): 449-55 (2005)
2011 71	Targeting inflammation in heart failure with histone deacetylase inhibitors. [21267510] Mol Med 17(5-6): 434-41 (2011)
2010 72	Electrophysiological remodeling in heart failure. [20096285] J Mol Cell Cardiol 48(4): 619-32 (2010)
2010 73	Extracellular matrix remodeling during the progression of volume overload-induced heart failure. [19524591] J Mol Cell Cardiol 48(3): 564-9 (2010)
2010 74	Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. [19559709] J Mol Cell Cardiol 48(3): 558-63 (2010)
2010 75	Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction. [19682461] J Mol Cell Cardiol 48(3): 483-9 (2010)
2009 76	Myocardial remodeling in low-renin hypertension: molecular pathways to cellular injury in relative aldosteronism. [19895752] Curr Hypertens Rep 11(6): 412-20 (2009)
2010 77	ADAMTS-7, a novel proteolytic culprit in vascular remodeling. [20717629] Sheng Li Xue Bao 62(4): 285-94 (2010)
PMC 78	Novel role of proline-rich nonreceptor tyrosine kinase 2 in vascular wall remodeling after balloon injury. [22922962] Arterioscler Thromb Vasc Biol 32(11):2652-61 (2012)
PMC 79	Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. [22997161] Cardiovasc Res 97(1):134-42 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Remodeling.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Remodeling.php on line 92